Drug Profile
Maroxepin
Alternative Names: CGP 13442ALatest Information Update: 06 Jan 1997
Price :
$50
*
At a glance
- Originator Novartis
- Class Antipsychotics; Anxiolytics; Dibenzazepines; Small molecules
- Mechanism of Action Dopamine receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Major depressive disorder; Psychotic disorders
Most Recent Events
- 06 Jan 1997 Discontinued-I for Depression in Germany (Unknown route)